Introduction
Lung cancer is one of the most common causes of mortality in the world. During the last 50 years, its incidence is dramatically increasing, not only in men but also in women. It is one of the few human cancers whose carcinogen is known. The incidence of lung cancer has been strongly linked to cigarette smoking. It also occurs in association with occupational and environmental exposure to carcinogenic agents. There are some other factors related to the development of lung cancer such as familial predisposition, genetic alteration, and more recently Helicobacter pylori infection. [1] [2] [3] H. pylori is a Gram-negative, spiral-shaped bacterium. The phenotypic differences between H. pylori isolates are production or non-production of a vacuolating cytotoxin, VacA, and a cytotoxin associated protein, CagA. 4 ability to produce these proteins. All other strains which do not have this ability belong to type II. Type I infections lead to more serious illnesses. 6 The International Agency for Research on Cancer of the World Health Organization recommends that H. pylori be classified as a group I carcinogen. 7 It has been showed that H. pylori infection may contribute to lung cancerogenesis via upregulation of gastrin and COX-2 that may account for the stimulation of tumor growth and angiogenesis. 3 The aim of this study was to determine the VacA, and CagA genotypes of H. pylori in patients with lung cancer and healthy controls, and compare the values of these two groups in an effort to elucidate a potential causative relationship.
Materials and methods

Study subjects
Forty-three histologically verified non-small cell lung cancer (NSCLC) patients and 28 controls, who were current smokers, were enrolled in the study. Lung carcinoma diagnosis was achieved by fiberoptic bronchoscopy and/or transthoracic needle aspiration. Controls were selected randomly from healthy patient family members. All subjects, controls and cancer patients, had neither gastric symptoms nor diagnosis of gastric cancer, peptic ulcer, or chronic gastritis.
Methods
H. pylori status was determined by immunoblot for the detection of IgG (RIDA Blot Helicobacter [RBiopharm GmbH, Darmstadt, Germany]). We took 5 cm 3 blood specimen from each patient before starting chemotherapy and from controls, and stored the sera at À70 1C. All materials were kept at room temperature for at least 30 min prior to use. Antigens of VacA and CagA positive isolates of H. pylori were separated electrophoretically by their molecular weight. They were blotted on a nitrocellulose membrane. The membrane was cut into single strips. These strips would be incubated with the samples (serum). Specific antibodies present in the samples would bind to the corresponding protein bands on the strip. After removing the unbound antibodies by washing, a second incubation with anti-human IgG conjugate followed. In a last step (staining reaction), specifically bound antibodies against the different H. pylori antigens become visible as blue bands on the strips. To evaluate a specimen, the incubation control band of the test strips were lined up with the control band of the strip of the evaluation template. With the kD statements of the evaluation template, the visible bands of the patient samples could be identified. 8 The bands received point values which were determined depending on the meaning of the bands and their detected immunoglobulin class. The evaluation of the sample was undertaken with regard to the total point value.
The point values of the antigen bands in the IgG test which were determined with mathematical analyses, are listed in Table 1 . A serum was IgGpositive if the total point number was larger than 12. It was IgG-negative if the total point number was smaller than 11.
Analysis
Statistical analysis was done by using GraphPad Prisma V3 program. Independent t-test was used for the comparison of groups and w 2 for the (Table 3 ). There were no significant differences in the prevalence of H. pylori between squamous lung cancer and adenocarcinoma patients (Fig. 1) .
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Discussion
H. pylori has become a world-wide infective agent ranging from 25% in developed countries to more than 80% in the developing world. 9 It is known that H. pylori infection has an important role in the development of chronic gastritis, peptic ulcer, gastric mucosa-associated lymphoid tissue (MALTlymphoma), and gastric cancer. [10] [11] [12] [13] It has also been shown that H. pylori infection leads to many respiratory illnesses as well.
14 This study demonstrates that lung cancer is associated with H. pylori infection. It has been reported that H. pylori infection with type I strain, which expresses the VacA and CagA antigen, is associated with more serious illnesses. 6 In our study, H. pylori seropositivity was significantly higher in cancer patients than in control subjects. Also more lung cancer cases were CagA-and VacA-positive patients than controls; however, only VacA seropositivity showed statistical significance. By comparison, a recent study reported that CagA strain seropositivity in lung cancer patients was about thrice as high as in controls (63% vs. 21.5%, respectively, Po0:05).
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Determination of the VacA and CagA gene together may contribute to delineation of patients who have different levels of risk. It has been put forward that CagA plays a partial role in increased mucosal inflammation, increased density of H. pylori in antrum, and causes more profound inhibition of mucin synthesis, duodenal ulcer, gastric ulcer and gastric cancer. 15 Many risk factors have been determined for H. pylori infection (CagA, VacA, IceA etc.), but none of them is specific for disease. 16 The opinion that VacA genotyping might be clinically useful, e.g. to predict presentation such as duodenal ulcer, has been proven wrong. 17 Virulence is a host-dependent factor. For instance, CagA-positive H. pylori strain is common in Thai patients with gastroduodenal diseases. 18 In our study, VacA seropositivity was significantly high in lung cancer patients. The reason for the higher prevalence of H. pylori infection in the lung cancer patients is not apparent but the fact that the majority of cancer patients were smokers, who are known to have higher H. pylori infection rate. 19, 20 Although smoking is thought to be related to H. pylori infection, some studies, supporting our findings, showed no significant relation between H. pylori seroconversion and smoking. 21 In Turkish population, smoking rate is high, the per capita yearly cigarette consumption over the age of 15 increased from 1850 in 1965 to 2600 in 1992. 22 In our study, control subjects as well as cancer patients were smokers; however, H. pylori seropositivity was significantly lower in control subjects than cancer patients. So H. pylori infection by itself may be a risk factor for lung cancer. Lungs arise embriologically from the same endodermal cells that form the lining of the gastrointestinal tract and possess similar cells releasing various hormonal peptides. 23 Increased plasma level of gastrin which is accompanied by H. pylori infection may contribute to the lung cancerogenesis by inducing mucosal cell proliferation of bronchial epithelium. 24 In the study done by Zhou et al. 25 it has been shown that serum from patients with lung cancer contained a high concentration of gastrin, and serum gastrin was found to decrease gradually after the removal of the tumor and to return to normal on the 14th postoperative day. In contrast, a study conducted by Dowlati et al. 26 demonstrated no evidence of clinical usefulness for gastrin measurements in lung cancer. There was no correlation with the stage of tumor and gastrin levels in the serum. Likewise in a study done to show seroprevalence results in Greek population, H. pylori seropositivity did not differ significantly between patients with lung cancer and controls. 27 Our results suggest that H. pylori infection may be associated with the development of lung cancer. However, further studies with larger numbers of patients are needed to further elucidate the potential pathogenetic relationship between H. pylori infections and lung cancer.
